Patient-reported outcomes used in clinical trials of systemic lupus erythematosus: a review of suitability for FDA labelling claims

dc.creator	Medić, Nenad
dc.creator	Zupan, Zorana
dc.creator	Hajdukova, Brown E.
dc.creator	Rudell, K.
dc.date.accessioned	2021-10-12T13:04:44Z
dc.date.available	2021-10-12T13:04:44Z
dc.date.issued	2019
dc.identifier.issn	1098-3015
dc.identifier.uri	http://reff.f.bg.ac.rs/handle/123456789/2891
dc.publisher	Elsevier Science Inc, New York
dc.rights	restrictedAccess
dc.source	Value in Health
dc.title	Patient-reported outcomes used in clinical trials of systemic lupus erythematosus: a review of suitability for FDA labelling claims	en
dc.type	conferenceObject
dc.rights.license	ARR
dc.citation.epage	S909
dc.citation.other	22: S909-S909
dc.citation.rank	aM21
dc.citation.spage	S909
dc.citation.volume	22
dc.identifier.rcub	https://hdl.handle.net/21.15107/rcub_reff_2891
dc.identifier.wos	000503167003418
dc.type.version	publishedVersion

Dokumenti

Datoteke	Veličina	Format	Pregled
Uz ovaj zapis nema datoteka.